NEW YORK (
) hit a new 52-week high Friday as it is currently trading at $39.99, above its previous 52-week high of $39.44 with 576,629 shares traded as of 9:35 a.m. ET. Average volume has been 3.6 million shares over the past 30 days.
Sanofi has a market cap of $101.51 billion and is part of the
industry. Shares are up 7.1% year to date as of the close of trading on Thursday.
Sanofi, together with its subsidiaries, researches, develops, manufactures, and markets healthcare products worldwide. The company has a P/E ratio of 20.3, above the average drugs industry P/E ratio of 13.6 and above the S&P 500 P/E ratio of 17.7.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
TheStreet Ratings rates Sanofi as a
. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full
52-week high stocks
or get investment ideas from our